AI assistant
DEXCOM INC — Director's Dealing 2024
Jan 18, 2024
30198_dirs_2024-01-17_3c2fe499-adec-490a-b4d4-793086d381c1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2024-01-12
Reporting Person: Stern Sadie (EVP Chief Human Resources)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-01-12 | Common Stock | A | 7620 | $0.001 | Acquired | 81953 | Direct |
| 2024-01-16 | Common Stock | S | 2902 | $123.6348 | Disposed | 79051 | Direct |
Footnotes
F1: Represents performance stock units ("PSUs") granted to the reporting person on March 8, 2021 that vested on January 12, 2024.
F2: Included in this number are 54,953 unvested restricted stock units, 21,769 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 14,124 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 3,340 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 7,512 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 8,208 of which were granted on November 19, 2020 and shall vest through November 19, 2024.
F3: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of PSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.